Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/19130147/ below:

Challenges in the management of positive fecal occult blood tests

Affiliations

• ¹ Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.

• PMID: 19130147
• PMCID: PMC2642561
• DOI: 10.1007/s11606-008-0893-5

Item in Clipboard

Sandhya K Rao et al. J Gen Intern Med. 2009 Mar.

• ¹ Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, MA, USA.

• PMID: 19130147
• PMCID: PMC2642561
• DOI: 10.1007/s11606-008-0893-5

Item in Clipboard

Background: Many patients with a positive fecal occult blood test (FOBT) do not undergo follow-up evaluations.

Objective: To identify the rate of follow-up colonoscopy following a positive FOBT and determine underlying reasons for lack of follow-up.

Design: It is a retrospective chart review.

Participants: The subject group consisted of 1,041 adults with positive FOBTs within a large physician group practice from 2004 to 2006.

Measurements: We collected data on reasons for ordering FOBT, presence of prior colonoscopy, completed evaluations, and results of follow-up tests. We fit a multivariable logistic regression model to identify predictors of undergoing follow-up colonoscopy.

Results: Most positive FOBTs were ordered for routine colorectal cancer screening (76%), or evaluation of anemia (13%) or rectal bleeding (7%). Colonoscopy was completed in 62% of cases, with one-third of these procedures identifying a colorectal adenoma (29%) or cancer (4%). Factors associated with higher rates of follow-up colonoscopy included obtaining the FOBT for routine colorectal screening (odds ratio (OR) 1.59, 95% confidence interval (CI) 1.11-2.29) and consultation with gastroenterology (OR 1.99, 95% CI 1.46-2.72). Patients were less likely to undergo colonoscopy if they were older than 80 years old (OR 0.54, 95% CI 0.31-0.92), younger than 50 years old (OR 0.44, 95% CI 0.28-0.70), uninsured (OR 0.50, 95% CI 0.27-0.93), or had undergone colonoscopy within the prior five years (OR 0.32, 95% CI 0.23-0.44).

Conclusions: Clinical decisions and patient factors available at the time of ordering an FOBT impact performance of colonoscopy. Targeting physicians' understanding of the use of this test may improve follow-up and reduce inappropriate use of this test.

PubMed Disclaimer

Planned and completed follow-up evaluations…

Planned and completed follow-up evaluations rates of planned and completed evaluations are indicated…

Planned and completed follow-up evaluations rates of planned and completed evaluations are indicated among 1,041 positive fecal occult blood tests.

• Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.

  Partin MR, Gravely AA, Burgess JF Jr, Haggstrom DA, Lillie SE, Nelson DB, Nugent SM, Shaukat A, Sultan S, Walter LC, Burgess DJ. Partin MR, et al. Cancer. 2017 Sep 15;123(18):3502-3512. doi: 10.1002/cncr.30765. Epub 2017 May 11. Cancer. 2017. PMID: 28493543 Free PMC article.

• Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

  Singh H, Kadiyala H, Bhagwath G, Shethia A, El-Serag H, Walder A, Velez ME, Petersen LA. Singh H, et al. Am J Gastroenterol. 2009 Apr;104(4):942-52. doi: 10.1038/ajg.2009.55. Epub 2009 Mar 17. Am J Gastroenterol. 2009. PMID: 19293786 Free PMC article.

• Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

  Hundt S, Haug U, Brenner H. Hundt S, et al. Ann Intern Med. 2009 Feb 3;150(3):162-9. doi: 10.7326/0003-4819-150-3-200902030-00005. Ann Intern Med. 2009. PMID: 19189905

• Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.

  Hirai HW, Tsoi KK, Chan JY, Wong SH, Ching JY, Wong MC, Wu JC, Chan FK, Sung JJ, Ng SC. Hirai HW, et al. Aliment Pharmacol Ther. 2016 Apr;43(7):755-64. doi: 10.1111/apt.13556. Epub 2016 Feb 9. Aliment Pharmacol Ther. 2016. PMID: 26858128 Review.

• Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis.

  Shah A, Eqbal A, Moy N, Koloski N, Messmann H, Kendall BJ, Sharma P, Dulleck U, Jones MP, Holtmann GJ. Shah A, et al. Gastrointest Endosc. 2023 Jun;97(6):1005-1015.e30. doi: 10.1016/j.gie.2023.02.013. Epub 2023 Feb 20. Gastrointest Endosc. 2023. PMID: 36812947 Review.

• Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.

  Baker DW, Brown T, Buchanan DR, Weil J, Cameron KA, Ranalli L, Ferreira MR, Stephens Q, Balsley K, Goldman SN, Wolf MS. Baker DW, et al. BMC Health Serv Res. 2013 Apr 29;13:153. doi: 10.1186/1472-6963-13-153. BMC Health Serv Res. 2013. PMID: 23627550 Free PMC article. Clinical Trial.

• Latinas' Colorectal Cancer Screening Knowledge, Barriers to Receipt, and Feasibility of Home-Based Fecal Immunochemical Testing.

  Warner EL, Bodson J, Mooney R, Lai D, Samadder NJ, Kepka D. Warner EL, et al. J Immigr Minor Health. 2018 Aug;20(4):981-990. doi: 10.1007/s10903-017-0615-3. J Immigr Minor Health. 2018. PMID: 28646404

• Implementing a multilevel intervention to accelerate colorectal cancer screening and follow-up in federally qualified health centers using a stepped wedge design: a study protocol.

  Kim K, Polite B, Hedeker D, Liebovitz D, Randal F, Jayaprakash M, Quinn M, Lee SM, Lam H. Kim K, et al. Implement Sci. 2020 Oct 29;15(1):96. doi: 10.1186/s13012-020-01045-4. Implement Sci. 2020. PMID: 33121536 Free PMC article.

• Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?

  Carlson CM, Kirby KA, Casadei MA, Partin MR, Kistler CE, Walter LC. Carlson CM, et al. Arch Intern Med. 2011 Feb 14;171(3):249-56. doi: 10.1001/archinternmed.2010.372. Epub 2010 Oct 11. Arch Intern Med. 2011. PMID: 20937917 Free PMC article.

• Improving the follow-up of positive hemoccult screening tests: an electronic intervention.

  Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Humphrey LL, et al. J Gen Intern Med. 2011 Jul;26(7):691-7. doi: 10.1007/s11606-011-1639-3. Epub 2011 Feb 15. J Gen Intern Med. 2011. PMID: 21327529 Free PMC article. Clinical Trial.

1. 1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.3322/CA.2007.0010', 'is_inner': False, 'url': 'https://doi.org/10.3322/ca.2007.0010'}, {'type': 'PubMed', 'value': '18287387', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/18287387/'}]}
   2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
2. 1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199305133281901', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199305133281901'}, {'type': 'PubMed', 'value': '8474513', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8474513/'}]}
   2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71. - PubMed
3. 1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(96)03386-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(96)03386-7'}, {'type': 'PubMed', 'value': '8942775', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8942775/'}]}
   2. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7. - PubMed
4. 1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(96)03430-7', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(96)03430-7'}, {'type': 'PubMed', 'value': '8942774', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8942774/'}]}
   2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71. - PubMed
5. 1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1736103', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1736103/'}]}
   2. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3